Sign In
Free Newsletter
Md. settles price-fixing lawsuit against Johnson & Johnson
Maryland has settled a price-fixing lawsuit against Johnson & Johnson Vision Care Inc. that alleged the company made a deal with retailers in 2014 to fix the price of its […]
J&J abandons claim women were urged to file bogus mesh cases
Johnson & Johnson, facing almost 24,000 lawsuits over its vaginal-mesh implants, withdrew a claim that women got calls from strangers who knew their personal medical information and asked them to file fraudulent cases.
Johnson & Johnson buying Alios for $1.75B
Johnson & Johnson is buying the biopharmaceutical company Alios BioPharma Inc. for about $1.75 billion.
Jury awards $3.27M in second vaginal-mesh lawsuit
Johnson & Johnson was ordered by a jury to pay $3.27 million to a woman who said a defectively designed vaginal-mesh implant eroded inside her and she had to have surgery.
J&J to settle hip-replacement suits for $2.5B
WASHINGTON — Johnson & Johnson said late Tuesday that it will pay $2.5 billion to settle thousands of lawsuits brought by hip replacement patients who accuse the company of selling […]
FDA OKs first-of-a-kind diabetes drug from J&J
WASHINGTON — The Food and Drug Administration says it has approved a first-of-a-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar. The agency […]
$8.3M awarded in DePuy hip implant case
LOS ANGELES — A jury on Friday awarded $8.3 million to a former prison guard who accused Johnson & Johnson‘s DePuy Orthopaedics subsidiary of knowingly marketing a faulty hip implant […]
Dancer drops DePuy suit, may join federal action
A former dancer has withdrawn her claim against Johnson & Johnson over faulty hip replacements on the same day the trial was to start.
J&J board picks CEO to replace retiring chairman
NEW BRUNSWICK, N.J. — Johnson & Johnson Chairman Bill Weldon will step down from that post in late December and the world’s biggest maker of health products has picked new […]
J&J, Pfizer to drop intravenous Alzheimer’s drug
NEW YORK — Pfizer Inc. and Johnson & Johnson said Monday they are ending development of an intravenous formulation of a drug to treat Alzheimer’s disease after the treatment failed […]
Like ‘Kleenex’ to ’tissue’, Apple’s ‘iPad’ is the only tablet people know
NEW YORK — Apple is on the verge of doing what few others have: change the English language. When you have a boo-boo, you reach for a Band-Aid not a […]
FDA panel backs birth control patch despite risks
ADELPHI — A panel of federal health advisers said Friday that a birth control patch from Johnson & Johnson probably carries a higher risk of blood clot risks than older […]
